NCT06651437

Brief Summary

A strong and well-known association exists between salt consumption, potassium intake, and cardiovascular diseases. MINISAL-SIIA results showed high salt and low potassium consumption in Italian hypertensive patients. In addition, a recent Italian survey showed that the degree of knowledge and behavior about salt was directly interrelated, suggesting a key role of the educational approach. Therefore, the present study will aim to evaluate the efficacy of a short-time dietary educational intervention (MINIMAL-ADVICE) on sodium and potassium intake in hypertensive patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
315

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable hypertension

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

5.5 years

First QC Date

September 5, 2024

Last Update Submit

November 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urinary Sodium and Potassium excretion (mmol/24h)

    Urinary sodium and potassium concentrations (mmol/24h) were measured by ion selective electrode potentiometry and urinary creatinine by a kinetic Jaffe reaction using an ABX Pentra 400 apparatus (HORIBA ABX, Rome, Italy). Quality control was effected using urine-specific reference samples from UrichemGol BIODEV (Milan, Italy).

    3 months

Secondary Outcomes (1)

  • Systolic and Diastolic Blood Pressure (mmHg)

    3 months

Study Arms (2)

Control

NO INTERVENTION

the Control group will not receive any additional information on diet

Dietary educational intervention

EXPERIMENTAL

The dietary educational intervention group received dietary education to gradually reduce salt intake (a brief dietary education on the health damage due to excess salt consumption and on behavioural methods to gradually reduce dietary intake, for example at home, reduce the consumption of processed foods, do not bring salt shaker on the table, limit the use of condiments with a high sodium content; out of home, both when eating and when shopping, reduce the consumption of processed foods, check nutritional labels and choose products with lower salt content). In addition, written information was provided.

Other: Experimental dietary educational intervention

Interventions

At the end of the baseline examination, the Experimental group received a brief dietary education on the health damage due to excess salt consumption and on behavioural methods to gradually reduce dietary intake, for example at home, reduce the consumption of processed foods, do not bring salt shaker on the table, limit the use of condiments with a high sodium content; out of home, both when eating and when shopping, reduce the consumption of processed foods, check nutritional labels and choose products with lower salt content. In addition, written information was provided. All participants will be clinically followed every month, with potential titration of the antihypertensive therapy. After 3 months of follow-up, the baseline measurements will be carried out again. During the entire study period, subjects will be asked to maintain their lifestyle and report using additional medications.

Also known as: Dietary educational intervention
Dietary educational intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult hypertensive patients with essential hypertension
  • assessment of organ damage
  • and stable antihypertensive treatment (lifestyle modifications and/or drug therapy) for at least 6 months

You may not qualify if:

  • patients with alteration in nutritional and absorptive status
  • glomerular filtration rate lower than 60 ml/min/1.73 m2
  • personal history positive for a recent cardiovascular event (less than 6 months)
  • atrial fibrillation or flutter, frequent atrial or ventricular premature contractions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • D'Elia L, Strazzullo P, Del Giudice A, Desideri G, Di Quattro R, Ferri C, Grossi A, Malatino L, Mallamaci F, Maresca A, Meschi M, Casola A, Nazzaro P, Pappaccogli M, Rabbia F, Sala C, Galletti F; MINISAL-SIIA Study Group. "Minimal-Advice" on Salt Intake: Results of a Multicentre Pilot Randomised Controlled Trial on Hypertensive Patients. High Blood Press Cardiovasc Prev. 2025 Mar;32(2):181-190. doi: 10.1007/s40292-025-00704-1. Epub 2025 Jan 30.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 5, 2024

First Posted

October 21, 2024

Study Start

July 1, 2016

Primary Completion

January 1, 2022

Study Completion

January 1, 2023

Last Updated

November 8, 2024

Record last verified: 2024-11